Skip to main content

Find Clinical Trials

Home
Conditions
Endocrine Gland Neoplasms

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,101 public trials 1,372 recruiting studies

Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

NCT02459652

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Aichi Cancer Center Nagoya, Aichi-ken, Japan

Nagoya University Hospital Nagoya, Aichi-ken, Japan

Hirosaki University Hospital Hirosaki, Aomori, Japan

National Cancer Center Hospital East Kashiwa, Chiba, Japan

View all 22 locations

View Trial Details

Completed

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT02283658

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer

NCT01899599

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Investigator Berlin, Germany

Investigator Kiel, Germany

Investigator Munich, Germany

Investigator Munich, Germany

View all 50 locations

View Trial Details

Completed

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies

NCT02340728

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Circulating Biomarkers to Identify Thyroid Cancer

NCT04594720

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Benign Thyroid Tumor, +12 more
Locations: Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan

View Trial Details

Completed

Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer

NCT01768156

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Institut Bergonié Bordeaux, France

CRLC Val d'Aurelle-Paul Lamarque Montpellier, France

View Trial Details

Completed

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

NCT02923921

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Cancer Treatment Centers of America Goodyear, Arizona, United States

University of Arizona Cancer Center Phoenix, Arizona, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

View all 130 locations

View Trial Details

Completed

Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours

NCT04122430

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +10 more
Locations: Walter and Eliza Hall Institute of Medical Research Parkville, Victoria, Australia

View Trial Details

Completed

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

NCT02704143

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Changhai hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Treatment of Pancreatic Cancer With Abraxane

NCT02555813

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: BHB Eisenstadt Eisenstadt, Austria

LKH Feldkirch Feldkirch, Austria

Medical University Graz Graz, Austria

Medical University Innsbruck Innsbruck, Austria

View all 19 locations

View Trial Details